logo

Puma Biotechnology Inc. (PBYI)



Trade PBYI now with
  Date
  Headline
7/26/2021 8:35:18 AM Puma Biotech Secures $125 Mln Note Purchase By Athyrium Capital
1/29/2021 8:02:49 AM Puma Biotechnology Presents Interim Results From Ongoing SUMMIT Trial Of Neratinib
1/15/2021 8:16:11 AM Puma Biotechnology Says Interim Results From Biliary Tract Cancers Cohort Of Phase 2 SUMMIT Basket Trial Of Neratinib
12/9/2020 7:54:11 PM Puma Biotechnology Presents Final Overall Survival Analysis From Phase III ExteNET Trial
7/16/2020 4:34:19 PM Puma Biotechnology: Licensing Partner STA Received Marketing Approval Of NERLYNX In Malaysia
2/26/2020 8:08:23 AM Puma Biotechnology Receives FDA Approval Of SNDA For Neratinib To Treat HER2-Positive Metastatic Breast Cancer
2/20/2020 5:25:07 PM Puma Biotechnology Reports Q4 Loss Per Share Of $0.29 Vs. $0.80 Last Year
3/2/2018 7:18:36 AM RBC Capital Markets Is Cutting Puma Biotechnology Inc. (PBYI) FY20 Rev. Estimate To 1032 M From 1072 M
3/2/2018 7:18:25 AM RBC Capital Markets Is Increasing Puma Biotechnology Inc. (PBYI) FY19 Rev. Estimate To 565.9 M From 561.3 M
3/2/2018 7:18:12 AM RBC Capital Markets Is Cutting Puma Biotechnology Inc. (PBYI) FY18 Rev. Estimate To 196.6 M From 198.6 M
3/2/2018 7:17:57 AM RBC Capital Markets Is Cutting Puma Biotechnology Inc. (PBYI) Q4 18 Rev. Estimate To 66.6 M From 70.1 M
3/2/2018 7:17:47 AM RBC Capital Markets Is Cutting Puma Biotechnology Inc. (PBYI) Q3 18 Rev. Estimate To 56.0 M From 56.4 M
3/2/2018 7:17:37 AM RBC Capital Markets Is Cutting Puma Biotechnology Inc. (PBYI) Q2 18 Rev. Estimate To 42.0 M From 42.2 M
3/2/2018 7:17:28 AM RBC Capital Markets Is Raising Puma Biotechnology Inc. (PBYI) Q1 18 Rev. Estimate To 32.0 M From 30.0 M
3/2/2018 7:17:06 AM RBC Capital Markets Is Raising Puma Biotechnology Inc. (PBYI) FY20 Estimate To 9.99 From 8.39
3/2/2018 7:16:51 AM RBC Capital Markets Is Raising Puma Biotechnology Inc. (PBYI) FY19 Estimate To 2.22 From 1.68